- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07942675
Indirect Calorimetry-Guided Nutritional Support in Mechanically Ventilated Children (CALI-PED) (CALI-PED)
Use of Indirect Calorimetry to Guide Caloric Intake in Children on Mechanical Ventilation in the Pediatric Intensive Care Unit: A Prospective Comparative Study
Adequate nutritional support is essential in critically ill children receiving invasive mechanical ventilation. Current nutritional prescriptions are commonly based on predictive equations, which may inaccurately estimate individual energy requirements and contribute to underfeeding or overfeeding.
CALI-PED is a single-center, prospective, interventional pilot study designed to evaluate whether indirect calorimetry-guided nutritional support reduces interindividual variability in energy intake adequacy among mechanically ventilated children in the pediatric intensive care unit (PICU).
Fifty children will be prospectively enrolled and compared with a historical cohort of 141 patients managed using conventional nutritional targets based on the Schofield predictive equation. In the prospective cohort, resting energy expenditure will be measured daily using indirect calorimetry, for up to seven days of invasive mechanical ventilation, and enteral caloric prescriptions will be adjusted accordingly.
The primary outcome is the interindividual variability in the ratio of actual energy intake to the reference energy target on days 2 and 3 of mechanical ventilation. Secondary outcomes include protein intake, agreement between predicted and measured energy requirements, changes in resting energy expenditure over time, duration of mechanical ventilation, PICU length of stay, and incidence of nosocomial infections.
This pilot study aims to determine whether indirect calorimetry can improve the individualization and consistency of nutritional support in critically ill children.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
**Background and Rationale** Nutritional support is a key component of pediatric intensive care. Inadequate nutritional intake has been associated with prolonged mechanical ventilation, increased nosocomial infections, longer intensive care and hospital stays, and higher mortality.
Current international guidelines recommend early nutritional assessment and suggest indirect calorimetry as the preferred method for determining resting energy expenditure (REE). However, nutritional prescriptions in routine clinical practice frequently rely on predictive equations, particularly the Schofield equation, which may not accurately reflect the metabolic requirements of critically ill children.
A previous retrospective study conducted in our PICU, involving 141 mechanically ventilated children, demonstrated persistent variability in energy intake on days 2 and 3 despite the implementation of a standardized enteral nutrition protocol. These findings suggest that individualizing energy targets using directly measured REE could improve nutritional adequacy.
**Study Design and Population** CALI-PED is a single-center, prospective, non-randomized, interventional pilot study conducted at Montpellier University Hospital, France.
The prospective cohort will include 50 children younger than 18 years, weighing at least 10 kg, receiving invasive mechanical ventilation through a cuffed endotracheal tube, with an expected ventilation duration exceeding 48 hours.
The prospective cohort will be compared with a previously collected historical cohort of 141 mechanically ventilated children managed using conventional nutritional targets based on the Schofield predictive equation.
**Intervention** In the prospective cohort, REE will be measured using the Q-NRG+ metabolic monitor (COSMED, Italy), connected to the mechanical ventilation circuit.
Measurements will be performed daily from day 2 until extubation, for a maximum of seven days. Before each measurement, respiratory settings must have remained unchanged for at least one hour. Oxygen consumption (VO2), carbon dioxide production (VCO2), REE, and respiratory quotient will be recorded over a 20-minute measurement period.
Daily enteral energy prescriptions will be adjusted according to the measured REE, expressed in kcal/day and kcal/kg/day.
**Primary Outcome** The primary outcome is the interindividual dispersion of the ratio between actual energy intake and the reference energy target on days 2 and 3 of mechanical ventilation.
The reference energy target will be defined as:
- Measured REE obtained by indirect calorimetry in the prospective cohort.
- Estimated energy requirements calculated using the Schofield equation in the historical cohort.
Interindividual dispersion will be assessed using the interquartile range and coefficient of variation.
**Secondary Outcomes**
Secondary outcomes include:
- Comparison of protein intake (g/kg/day) between cohorts on days 2 and 3.
- Comparison of Schofield-predicted energy requirements with indirect calorimetry-measured REE in the prospective cohort.
- Description of daily changes in measured REE during invasive mechanical ventilation, up to day 7.
- Exploratory comparison of mechanical ventilation duration, PICU length of stay, and incidence of nosocomial infections between cohorts.
Nosocomial infections will be defined as infections occurring at least 48 hours after admission, according to Centers for Disease Control and Prevention criteria.
**Statistical Analysis** The distributions of energy intake adequacy ratios will be compared between the prospective and historical cohorts using appropriate statistical methods. Normality will be assessed using the Shapiro-Wilk test, and continuous variables will be compared using parametric or non-parametric tests as appropriate.
Additional analyses may account for differences between the prospective and historical cohorts, including propensity score methods.
Clinical outcomes will be considered exploratory, as the study is not powered to demonstrate differences in clinical endpoints.
**Study Duration and Ethical Considerations** The recruitment period is expected to last 30 months. Participants will be followed until PICU discharge or day 28 after inclusion, whichever occurs first.
The study was approved by the Comité de Protection des Personnes Île-de-France VII on August 5, 2026 (reference 26.02032.000560). Written informed consent will be obtained from at least one parent or legal guardian, and assent will be obtained from the child whenever feasible.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Arthur Gavotto, MD, PhD
- Número de telefone: +33 4 67 33 66 09
- E-mail: a-gavotto@chu-montpellier.fr
Locais de estudo
-
-
Occitanie
-
Montpellier, Occitanie, França, 34295
- Montpellier University Hospital - Arnaud de Villeneuve Hospital
-
Contato:
- Arthur Gavotto, MD, PhD
- Número de telefone: +33 4 67 33 66 09
- E-mail: a-gavotto@chu-montpellier.fr
-
Investigador principal:
- Arthur Gavotto, MD, PhD
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Children younger than 18 years of age.
- Body weight ≥10 kg.
- Invasive mechanical ventilation.
- Expected duration of invasive mechanical ventilation >48 hours.
- Child's assent to participate, whenever feasible.
- Written informed consent obtained from at least one parent or legal guardian.
Exclusion Criteria:
- Limitation or withdrawal of life-sustaining treatment planned at the time of admission to the pediatric intensive care unit.
- Brain death.
- Requirement for a specific dietary regimen due to an underlying condition, including diabetic ketoacidosis or an inherited metabolic disorder.
- Gastrointestinal disorders interfering with enteral nutrition, including short bowel syndrome or malabsorption.
- Participation in another research study with an ongoing exclusion period.
- Concurrent participation in another interventional clinical trial that could interfere with the present study.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Indirect Calorimetry-Guided Nutrition
Fifty mechanically ventilated children will receive individualized enteral nutritional support guided by daily indirect calorimetry measurements. Resting energy expenditure will be measured from day 2 until extubation, for a maximum of seven days, and enteral caloric prescriptions will be adjusted accordingly. |
Resting energy expenditure (REE) will be measured using the Q-NRG+ metabolic monitor (COSMED, Italy), connected to the mechanical ventilation circuit. Measurements will be performed daily from day 2 until extubation, for a maximum of seven days. Oxygen consumption (VO2), carbon dioxide production (VCO2), REE, and respiratory quotient will be recorded over a 20-minute measurement period. Daily enteral caloric prescriptions will be adjusted according to the measured REE. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Interindividual Variability in Energy Intake Adequacy on Days 2 and 3 of Mechanical Ventilation
Prazo: Days 2 and 3 of invasive mechanical ventilation
|
Interindividual variability in the ratio of actual energy intake (kcal/kg/day) to the reference energy target will be compared between the prospective and historical cohorts on days 2 and 3 of mechanical ventilation. The reference energy target is defined as resting energy expenditure measured by indirect calorimetry in the prospective cohort and energy requirements estimated using the Schofield equation in the historical cohort. Interindividual variability will be primarily quantified using the interquartile range (IQR) of the energy intake adequacy ratio. The coefficient of variation (CV) will be calculated as a complementary measure of dispersion. |
Days 2 and 3 of invasive mechanical ventilation
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Daily Protein Intake on Days 2 of Mechanical Ventilation
Prazo: Days 2 of invasive mechanical ventilation
|
Comparison of actual protein intake, expressed in grams per kilogram of body weight per day (g/kg/day), between the prospective and historical cohorts on days 2 of invasive mechanical ventilation. |
Days 2 of invasive mechanical ventilation
|
|
Daily Protein Intake on Days 3 of Mechanical Ventilation
Prazo: Days 3 of invasive mechanical ventilation
|
Comparison of actual protein intake, expressed in grams per kilogram of body weight per day (g/kg/day), between the prospective and historical cohorts on days 3 of invasive mechanical ventilation. |
Days 3 of invasive mechanical ventilation
|
|
Difference Between Predicted and Measured Resting Energy Expenditure
Prazo: Days 2 to 7 of invasive mechanical ventilation
|
Difference between energy requirements estimated using the Schofield predictive equation and resting energy expenditure measured by indirect calorimetry in the prospective cohort, expressed in kcal/day. |
Days 2 to 7 of invasive mechanical ventilation
|
|
Daily Changes in Measured Resting Energy Expenditure
Prazo: Days 2 to 7 of invasive mechanical ventilation
|
Daily resting energy expenditure measured by indirect calorimetry, expressed in kcal/day, will be described from day 2 until extubation, for a maximum of seven days of invasive mechanical ventilation, in the prospective cohort. |
Days 2 to 7 of invasive mechanical ventilation
|
|
Duration of Invasive Mechanical Ventilation
Prazo: From initiation of invasive mechanical ventilation until extubation, assessed up to day 28 after enrollment
|
Duration of invasive mechanical ventilation, expressed in days, will be compared between the prospective and historical cohorts as an exploratory clinical outcome. |
From initiation of invasive mechanical ventilation until extubation, assessed up to day 28 after enrollment
|
|
Pediatric Intensive Care Unit Length of Stay
Prazo: From PICU admission until PICU discharge, assessed up to day 28 after enrollment
|
Length of stay in the pediatric intensive care unit, expressed in days, will be compared between the prospective and historical cohorts as an exploratory clinical outcome. |
From PICU admission until PICU discharge, assessed up to day 28 after enrollment
|
|
Incidence of Nosocomial Infections
Prazo: From 48 hours after PICU admission until PICU discharge or day 28 after enrollment, whichever occurs first
|
Proportion of patients developing at least one nosocomial infection, defined as an infection occurring at least 48 hours after PICU admission according to Centers for Disease Control and Prevention criteria. This exploratory clinical outcome will be compared between the prospective and historical cohorts. |
From 48 hours after PICU admission until PICU discharge or day 28 after enrollment, whichever occurs first
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Arthur Gavotto, University Hospital, Montpellier
Publicações e links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- RECHMPL23_0109
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Individual participant data will not be made publicly available due to the sensitive nature of clinical information collected from critically ill pediatric patients and applicable data protection requirements. Study results will be disseminated through scientific publications and presentations in aggregated form.
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .